UK microbiology company Lab M has appointed Harnek Singh as export sales manager with responsibility for the Middle East, Eastern Europe, Central Asia and Africa.
Singh is a microbiologist with extensive commercial experience and graduate member of the British Institute of Export. He will work alongside fellow export sales manager Veronica Ponnuthurai who is responsible for supporting Western Europe, Asia Pacific and the Americas for Lab M.
The company, based in Bury, Lancashire, says this expansion of its export sales team reflects continued growth and the development of new opportunities in markets around the world.
‘With his extensive knowledge of sales in the food and clinical industries and major commercial experience in the Middle East, Asia and Africa, Harnek Singh brings great experience and energy to this new role within the export sales team. It is my pleasure to welcome him to the company,’ said Phil Large, Lab M’s sales and marketing manager.
Lab M appoints export sales manager
With responsibility for the Middle East, Eastern Europe, Central Asia and Africa
You may also like
Manufacturing
Patented device reinvents Solid Phase Extraction
Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Analysis
Standardising cell-based potency assays for biologics lot release: the case for cryopreserved ready-to-use cell systems (part II)
Standardised cell systems can reduce biological variability, but robust potency testing must also demonstrate accuracy, precision and linearity. ICH Q2(R2) provides the framework to establish this analytical confidence
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Analysis
Standardising cell-based potency assays for biologics lot release: the case for cryopreserved ready-to-use cell systems (part I)
As biologics become increasingly complex, demonstrating consistent biological activity at lot release is essential. Yet the cell-based assays used to measure potency introduce significant challenges in standardisation, reproducibility and regulatory compliance